Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing Facilities
Pharma
Novartis hit with FDA letter over manufacturing of CAR-T Kymriah
In recent months, Novartis has faced scrutiny from the FDA over Kymriah production shortfalls, a newly posted letter shows.
Fraiser Kansteiner
Dec 7, 2023 9:23am
Fujifilm blueprints $200M investment across two production units
Dec 4, 2023 2:24pm
WuXi Bio struggles amid CDMO industry downturn, stock plummets
Dec 4, 2023 10:12am
The FDA handed down 2 new Forms 483 this week
Nov 30, 2023 10:50am
Amgen expands pact with Amazon to deploy AI in drug production
Nov 29, 2023 11:11am
Novo to invest $2.3B to expand production of GLP-1s in France
Nov 27, 2023 10:40am
